attachment
attachment

Why not option A

Reading File
analyse_media
!

No generations found in stream.

We encountered an error while processing your request. Please try again or reach out to us for help.

attachment
attachment

Why novotion a

Reading File
analyse_media
Finding Sources
Searching PubMed

asthma AND corticosteroids

Searching the Web

GINA 2025 asthma oral corticosteroids maintenance low dose inhaled corticosteroid treatment

Option A, oral prednisolone 10 mg daily, is not appropriate because this patient does not have a severe acute exacerbation or severe treatment-resistant asthma.
She has partly controlled asthma:
  • Night-time symptoms once weekly
  • Reliever use twice weekly
  • FEV1 improves with bronchodilator, indicating reversible airflow obstruction
The appropriate next step is to add a controller medication, specifically an inhaled corticosteroid (ICS). Therefore, among these options, C: fluticasone propionate 40 micrograms twice daily is best.
Why avoid long-term oral prednisolone here:
  • It is systemic corticosteroid treatment, reserved for a short course during significant exacerbations or, rarely, as a last-resort maintenance treatment in severe asthma.
  • Daily oral prednisolone causes substantial cumulative toxicity: weight gain, diabetes, hypertension, osteoporosis, cataracts, adrenal suppression, infection risk, and mood effects.
  • An ICS targets airway inflammation directly with far fewer systemic effects.
So the logic is:
Partly controlled asthma on SABA alone → add low-dose inhaled steroid, not daily oral steroid.
Also, B and D are wrong because SABA-only treatment does not treat the underlying airway inflammation, and scheduled salbutamol can promote over-reliance on reliever therapy. Current GINA guidance similarly says maintenance oral corticosteroids should be only a last resort because of serious systemic adverse effects, while asthma treatment should contain an inhaled corticosteroid. GINA asthma guidance
This is a shared conversation. Sign in to Orris to start your own chat.